Page results
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page provides information about the thermoregulatory sweat test (TST).
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
This page has been written for patients at Eastman Dental Hospital who are undergoing intravenous sedation.
File results
-
FOI/2024/0184 - IT spend/ Healthcare Information and Management Systems Society (HIMSS) EMRAM and INFRAM scores
-
FOI/2024/0190 - Scheduled appointments Did Not Attend (DNA) 2019-2023
-
FOI/2024/0192 - Net zero and decarbonisation targets
-
FOI/2024/0462 - Patient information leaflets and e-consent systems
-
FOI/2024/0198 - Nurse intake at Band 5
-
FOI/2024/0199 - Admission and discharge policies for violent assault injuries/ autism/ patient records/ inaccurate records
-
FOI/2024/0204 - Clinical insourcing for audiology and pathology
-
FOI/2024/0206 - Trusts budget allocated for cancer funding 2019/20-2023/24
-
FOI/2024/0207 - Physician Associates and prescribing/ ionising radiation
-
FOI/2024/0214 - Treatment for myeloproliferative neoplasms